It is also well known that blood-brain barrier integrity is compromised in glioblastoma, which may correlate with the elevated sera MMP-9 levels detected, as secreted MMP-9 readily crosses the disrupted blood-brain barrier (39) and enters the patient’s systemic circulation, where its levels can be measured to indicate disease progression or recurrence. The gene discussed is MMP9; the disease is glioblastoma.